Molina Healthcare (NYSE:MOH - Get Free Report) was upgraded by Wall Street Zen from a "sell" rating to a "hold" rating in a report released on Saturday.
A number of other equities analysts also recently commented on MOH. Zacks Research raised shares of Molina Healthcare from a "strong sell" rating to a "hold" rating in a report on Monday, April 20th. The Goldman Sachs Group decreased their price objective on shares of Molina Healthcare from $167.00 to $124.00 and set a "neutral" rating for the company in a report on Wednesday, February 11th. UBS Group lifted their price objective on shares of Molina Healthcare from $151.00 to $180.00 and gave the stock a "neutral" rating in a report on Friday, April 24th. Barclays lifted their price objective on shares of Molina Healthcare from $133.00 to $161.00 and gave the stock an "underweight" rating in a report on Friday, April 24th. Finally, Weiss Ratings reaffirmed a "sell (d+)" rating on shares of Molina Healthcare in a report on Tuesday, April 21st. Three investment analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have assigned a Sell rating to the company's stock. According to data from MarketBeat.com, Molina Healthcare has an average rating of "Hold" and an average target price of $169.60.
View Our Latest Research Report on MOH
Molina Healthcare Stock Performance
Molina Healthcare stock opened at $192.74 on Friday. The company has a market cap of $10.04 billion, a PE ratio of 57.02, a P/E/G ratio of 1.92 and a beta of 0.84. The company has a fifty day moving average price of $149.82 and a two-hundred day moving average price of $158.97. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.63 and a quick ratio of 1.63. Molina Healthcare has a 12 month low of $121.06 and a 12 month high of $333.00.
Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, topping analysts' consensus estimates of $1.57 by $0.78. The firm had revenue of $10.80 billion during the quarter, compared to the consensus estimate of $10.91 billion. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The firm's revenue was down 3.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $6.08 earnings per share. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Research analysts expect that Molina Healthcare will post 5.21 earnings per share for the current year.
Institutional Investors Weigh In On Molina Healthcare
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. ARGA Investment Management LP raised its stake in shares of Molina Healthcare by 1.4% during the first quarter. ARGA Investment Management LP now owns 4,166 shares of the company's stock valued at $555,000 after purchasing an additional 59 shares in the last quarter. Blue Trust Inc. raised its stake in shares of Molina Healthcare by 23.8% during the fourth quarter. Blue Trust Inc. now owns 322 shares of the company's stock valued at $56,000 after purchasing an additional 62 shares in the last quarter. Asset Management One Co. Ltd. raised its stake in shares of Molina Healthcare by 0.3% during the third quarter. Asset Management One Co. Ltd. now owns 22,737 shares of the company's stock valued at $4,351,000 after purchasing an additional 66 shares in the last quarter. Applied Finance Capital Management LLC raised its stake in shares of Molina Healthcare by 5.7% during the third quarter. Applied Finance Capital Management LLC now owns 1,408 shares of the company's stock valued at $269,000 after purchasing an additional 76 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd raised its stake in shares of Molina Healthcare by 64.5% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 232 shares of the company's stock valued at $40,000 after purchasing an additional 91 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors.
Molina Healthcare Company Profile
(
Get Free Report)
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.